S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
Log in

OTCMKTS:IVOB - Invo Bioscience Stock Price, Forecast & News

$0.26
0.00 (-0.04 %)
(As of 02/20/2020 04:00 PM ET)
Today's Range
$0.24
Now: $0.26
$0.26
50-Day Range
$0.20
MA: $0.24
$0.27
52-Week Range
$0.17
Now: $0.26
$0.47
Volume43,315 shs
Average Volume41,006 shs
Market Capitalization$40.90 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.96
INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IVOB
CUSIPN/A
CIKN/A
Phone978-878-9505

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$490,000.00
Book Value($0.02) per share

Profitability

Net Income$-3,080,000.00
Net Margins-166.95%

Miscellaneous

Employees2
Market Cap$40.90 million
Next Earnings Date4/21/2020 (Estimated)
OptionableNot Optionable

Receive IVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter.


Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions

What is Invo Bioscience's stock symbol?

Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."

How were Invo Bioscience's earnings last quarter?

Invo Bioscience Inc (OTCMKTS:IVOB) announced its quarterly earnings results on Tuesday, August, 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.11 million for the quarter. View Invo Bioscience's Earnings History.

When is Invo Bioscience's next earnings date?

Invo Bioscience is scheduled to release their next quarterly earnings announcement on Tuesday, April 21st 2020. View Earnings Estimates for Invo Bioscience.

Has Invo Bioscience been receiving favorable news coverage?

News coverage about IVOB stock has been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Invo Bioscience earned a daily sentiment score of -2.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Invo Bioscience.

Who are some of Invo Bioscience's key competitors?

What other stocks do shareholders of Invo Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invo Bioscience investors own include Pharmacyte Biotech (PMCB), Co-Diagnostics (CODX), Sierra Oncology (SRRA), Ibio (IBIO), Ascent Solar Technologies (ASTI), SANUWAVE Health (SNWV), Digital Ally (DGLY), FuelCell Energy (FCEL), Globalstar (GSAT) and Inovio Pharmaceuticals (INO).

Who are Invo Bioscience's key executives?

Invo Bioscience's management team includes the folowing people:
  • Ms. Kathleen T. Karloff, Chairman, CEO & Pres (Age 64)
  • Mr. Robert Joseph Bowdring Jr., Acting CFO, Acting Principal Accounting Officer, Treasurer, Sec., Consultant & Director (Age 61)
  • Mr. Michael Jos. Campbell, COO, VP of Bus. Devel. & Director (Age 61)
  • Dr. Kevin Doody, Medical Director & Director (Age 58)

How do I buy shares of Invo Bioscience?

Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Invo Bioscience's stock price today?

One share of IVOB stock can currently be purchased for approximately $0.26.

How big of a company is Invo Bioscience?

Invo Bioscience has a market capitalization of $40.90 million and generates $490,000.00 in revenue each year. Invo Bioscience employs 2 workers across the globe.View Additional Information About Invo Bioscience.

What is Invo Bioscience's official website?

The official website for Invo Bioscience is http://www.invobioscience.com/.

How can I contact Invo Bioscience?

Invo Bioscience's mailing address is 5582 BROADCAST COURT, SARASOTA FL, 34240. The company can be reached via phone at 978-878-9505 or via email at [email protected]


MarketBeat Community Rating for Invo Bioscience (OTCMKTS IVOB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  125 (Thanks for Voting!)
Underperform Votes:  118 (Thanks for Voting!)
Total Votes:  243
MarketBeat's community ratings are surveys of what our community members think about Invo Bioscience and other stocks. Vote "Outperform" if you believe IVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVOB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel